[go: up one dir, main page]

ES2061718T3 - Utilizacion de antigestagenos para la preparacion de medicamentos. - Google Patents

Utilizacion de antigestagenos para la preparacion de medicamentos.

Info

Publication number
ES2061718T3
ES2061718T3 ES88730281T ES88730281T ES2061718T3 ES 2061718 T3 ES2061718 T3 ES 2061718T3 ES 88730281 T ES88730281 T ES 88730281T ES 88730281 T ES88730281 T ES 88730281T ES 2061718 T3 ES2061718 T3 ES 2061718T3
Authority
ES
Spain
Prior art keywords
antigestagens
medicines
preparation
nonpregnant
cervix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88730281T
Other languages
English (en)
Inventor
Krzysztof Dr Chwalisz
Sybille Dr Beier
Angelika Esch
Walter Dr Elger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2061718T3 publication Critical patent/ES2061718T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

UTILIZACION DE ANTIGESTAGENOS PARA LA FABRICACION DE MEDICAMENTOS CON EFECTO DE ABLANDAMIENTO DEL CERVIX FUERA DE LA GRAVIDEZ.
ES88730281T 1987-12-21 1988-12-20 Utilizacion de antigestagenos para la preparacion de medicamentos. Expired - Lifetime ES2061718T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873744054 DE3744054A1 (de) 1987-12-21 1987-12-21 Verwendung von antigestagenen zur herstellung von arzneimitteln

Publications (1)

Publication Number Publication Date
ES2061718T3 true ES2061718T3 (es) 1994-12-16

Family

ID=6343574

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88730281T Expired - Lifetime ES2061718T3 (es) 1987-12-21 1988-12-20 Utilizacion de antigestagenos para la preparacion de medicamentos.

Country Status (6)

Country Link
US (1) US4891368A (es)
EP (1) EP0322352B1 (es)
JP (1) JP2636914B2 (es)
AT (1) ATE98491T1 (es)
DE (2) DE3744054A1 (es)
ES (1) ES2061718T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978657A (en) * 1981-01-09 1990-12-18 Roussel Uclaf Novel 11β-substituted-19-nor-steroids
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
US5681817A (en) 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA18433A1 (fr) * 1978-05-26 1979-12-31 Ciba Geigy Ag Procede pour la synthese de la chaine laterale hydroxyacetyle de steroides du type pregnagne, nouveaux 21-hydroxy-20-oxo-17 alpha-pregnagnes et produits pharmaceutiques en renfermant
US4780461A (en) * 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same

Also Published As

Publication number Publication date
EP0322352B1 (de) 1993-12-15
JPH01211526A (ja) 1989-08-24
EP0322352A3 (en) 1989-12-20
US4891368A (en) 1990-01-02
EP0322352A2 (de) 1989-06-28
JP2636914B2 (ja) 1997-08-06
ATE98491T1 (de) 1994-01-15
DE3744054A1 (de) 1989-06-29
DE3886367D1 (de) 1994-01-27

Similar Documents

Publication Publication Date Title
BR8707937A (pt) Protese para osteosintese
MX164971B (es) Procedimiento para la preparacion de conjugados de medicamentos citoxicos
MX7769A (es) Procedimiento para la preparacion de derivados de pirimidina.
ES2013727B3 (es) Procedimiento para la fabricacion de articulos de cerdas y articulos de cerdas fabricadas por dicho procedimiento.
FR2651435B1 (es)
IT1219250B (it) Procedimento per la preparazione di idrocarburi
ES2024611B3 (es) Procedimiento para la obtencion de 1 - arilo - 1 - alquenos
ES2061718T3 (es) Utilizacion de antigestagenos para la preparacion de medicamentos.
ES2013216A4 (es) Proceso para la preparacion de n - fosfonometilglicina
ES2022952B3 (es) Proceso para la preparacion de naftacenos
ES491455A0 (es) Procedimiento para la fabricacion de medicamentos de dihy- droergotoxina
ES2020587B3 (es) Procedimiento para la elaboracion de acidos de trifluormetana - sulfona
MX163596B (es) Procedimiento para la preparacion de resorcinol
ES2002602B3 (es) Procedimiento para fabricacion de partes de conexion.
MX17041A (es) Procedimiento para la preparacion de benzopirano pirazoles.
MX11650A (es) Procedimiento para la preparacion de compuestos denaftil-azo-pirazolona
IT8722911A0 (it) Procedimento per la preparazione di monosialoganglioside.
MX12003A (es) Procedimiento para la preparacion de composicionesherbicidas.
ES2018532B3 (es) Procedimiento para la preparacion de compuestos carbonilicos.
IT8719083A0 (it) Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
IT8723035A0 (it) Procedimento per la preparazione di n acilaniline.
ES555113A0 (es) Procedimiento para la obtencion de escualano
ES532393A0 (es) Procedimiento para la preparacion del citrato de la (+) vinpocetina
ES524353A0 (es) Procedimiento para la preparacion de n-metil-n-bis-(3,4-dimetoxi-fenil-etil)-amina
MX164640B (es) Proceso para la preparacion de 1-metil-2-pirrolidona

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 322352

Country of ref document: ES